Multiplex Platform TechnologyDiscover how EDP's platform technology allows us to build early detection diagnostic tests.
EDP Biotech Corporation performs research and develops products to identify and purify proteins present in the early stages of biological changes for production of in vitro diagnostic tests whose primary target is early detection.
ColoMarker utilizes a multiplex platform technology capable of running on an automated platform, in order to measure numerous biomarker proteins in the same patient blood sample. The kit includes all components necessary to run patient serum in duplicate, including controls and calibrators.
EDP Biotech has conducted multiple clinical research studies with approved IRBs.